{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:12:26Z","timestamp":1760145146298,"version":"build-2065373602"},"reference-count":68,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["P20GM103648","R21DE029733"],"award-info":[{"award-number":["P20GM103648","R21DE029733"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institute of Dental and Craniofacial Research (NIDCR) of the National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["P20GM103648","R21DE029733"],"award-info":[{"award-number":["P20GM103648","R21DE029733"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>People living with human immunodeficiency virus (PLWH) are a significant population globally. Research delineating our understanding of coinfections in PLWH is critical to care for those navigating infection with other pathogens. The recent COVID-19 pandemic underscored the urgent need for studying the effects of SARS-CoV-2 infections in therapy-controlled and uncontrolled immunodeficiency viral infections. This study established the utility of a feline model for the in vivo study of coinfections. Domestic cats are naturally infected with SARS-CoV-2 and Feline Immunodeficiency Virus, a lentivirus molecularly and pathogenically similar to HIV. In this study, comparisons are made between FIV-positive and FIV-negative cats inoculated with SARS-CoV-2 (B.1.617.2.) in an experimental setting. Of the FIV+ cats, three received Zidovudine (AZT) therapy in the weeks leading up to SARS-CoV-2 inoculation, and two did not. SARS-CoV-2 viral RNA was quantified, histopathologic comparisons of respiratory tissues were made, and T-cell populations were analyzed for immune phenotype shifts between groups. CD4+ T lymphocyte responses varied, with FIV+-untreated cats having the poorest CD4+ response to SARS-CoV-2 infection. While all cats had significant pulmonary inflammation, key histopathologic features of the disease differed between groups. Additionally, viral genomic analysis was performed, and results were analyzed for the presence of emerging, absent, amplified, or reduced mutations in SARS-CoV-2 viral RNA after passage through the feline model. Positive selection is noted, especially in FIV+ cats untreated with AZT, and mutations with potential relevance were identified; one FIV+-untreated cat had persistent, increasing SARS-CoV-2 RNA in plasma five days post-infection. These findings and others support the utility of the feline model for studying coinfection in people with HIV and highlight the importance of antiretroviral therapy in clearing SARS-CoV-2 coinfections to minimize transmission and emergence of mutations that may have deleterious effects.<\/jats:p>","DOI":"10.3390\/microorganisms12071289","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T10:10:07Z","timestamp":1719310207000},"page":"1289","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Utilizing Feline Lentiviral Infection to Establish a Translational Model for COVID-19 in People with Human Immunodeficiency Virus Infection"],"prefix":"10.3390","volume":"12","author":[{"given":"Shoroq","family":"Shatnawi","sequence":"first","affiliation":[{"name":"Department of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9017-2538","authenticated-orcid":false,"given":"Sachithra","family":"Gunasekara","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bashor","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80521, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miruthula","family":"Tamil Selvan","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Nehring","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80521, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Cowan","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Ritchey","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9227-1622","authenticated-orcid":false,"given":"Susan","family":"VandeWoude","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80521, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brianne","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3638-5665","authenticated-orcid":false,"given":"Craig","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4532-3458","authenticated-orcid":false,"given":"Jennifer M.","family":"Rudd","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"key":"ref_1","unstructured":"(2022, April 04). Global HIV Statistics. Available online: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset."},{"key":"ref_2","unstructured":"(2024, April 11). HIV and AIDS Resources, Available online: https:\/\/www.hiv.gov."},{"key":"ref_3","unstructured":"(2022, May 14). WHO Coronavirus, Dashboard. COVID-19 Who Int. Available online: https:\/\/data.who.int\/dashboards\/covid19\/cases."},{"key":"ref_4","unstructured":"(2024, February 18). CDC People with Certain Medical Conditions, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12981-021-00427-y","article-title":"Outcomes of patients with HIV and COVID-19 co-infection: A systematic review and meta-analysis","volume":"19","author":"Danwang","year":"2022","journal-title":"AIDS Res. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e26573","DOI":"10.1097\/MD.0000000000026573","article-title":"HIV infection and risk of COVID-19 mortality: A meta-analysis","volume":"100","author":"Dong","year":"2021","journal-title":"Medicine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/S2352-3018(20)30305-2","article-title":"HIV infection and COVID-19 death: A population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform","volume":"8","author":"Bhaskaran","year":"2021","journal-title":"Lancet HIV"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41591-022-02156-9","article-title":"Comorbidities, multimorbidity and COVID-19","volume":"29","author":"Russell","year":"2023","journal-title":"Nat. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"15E.2.1-9","DOI":"10.1002\/9780471729259.mc15e02s37","article-title":"Growth and Quantification of MERS-CoV Infection","volume":"37","author":"Coleman","year":"2015","journal-title":"Curr. Protoc. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s10238-023-01036-x","article-title":"Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: Results from a real-world retrospective study","volume":"23","author":"Mengato","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e28660","DOI":"10.1002\/jmv.28660","article-title":"Risk of Hospitalization and Sequelae in Patients with COVID-19 Treated with 3-Day Early Remdesivir vs. Controls in the Vaccine and Omicron era: A Real-Life Cohort Study","volume":"95","author":"Mazzitelli","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.clinthera.2022.01.007","article-title":"Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients with Mild to Moderate COVID-19","volume":"44","author":"Falcone","year":"2022","journal-title":"Clin. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/jmv.26049","article-title":"COVID-19 in a patient with HIV infection","volume":"92","author":"Patel","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/apc.2020.0103","article-title":"A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois","volume":"34","author":"Ridgway","year":"2020","journal-title":"AIDS Patient Care STDs"},{"key":"ref_15","first-page":"184","article-title":"The immune response to SARS-CoV-2 in people with HIV","volume":"21","author":"Burgers","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Rudd, J.M., Tamil Selvan, M., Cowan, S., Kao, Y.-F., Midkiff, C.C., Narayanan, S., Ramachandran, A., Ritchey, J.W., and Miller, C.A. (2021). Clinical and Histopathologic Features of a Feline SARS-CoV-2 Infection Model Are Analogous to Acute COVID-19 in Humans. Viruses, 13.","DOI":"10.1101\/2021.04.14.439863"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Hosie, M.J., and Lutz, H. (2022). Feline Immunodeficiency Virus. Schalm\u2019s Veterinary Hematology, John Wiley & Sons, Ltd.","DOI":"10.1002\/9781119500537.ch53"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.3390\/v3112192","article-title":"The Molecular Biology of Feline Immunodeficiency Virus (FIV)","volume":"3","author":"Kenyon","year":"2011","journal-title":"Viruses"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1126\/science.3643650","article-title":"Isolation of a T-Lymphotropic Virus from Domestic Cats with an Immunodeficiency-Like Syndrome","volume":"235","author":"Pedersen","year":"1987","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/157016210790416389","article-title":"Feline Immunodeficiency Virus (FIV) as A Model for Study of Lentivirus Infections: Parallels with HIV","volume":"8","author":"Elder","year":"2010","journal-title":"Curr. HIV Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1570162033352101","article-title":"Transmission and Immunopathogenesis of FIV in Cats as a Model for HIV","volume":"1","author":"Burkhard","year":"2003","journal-title":"Curr. HIV Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Friedman, H., Specter, S., and Bendinelli, M. (2006). FIV as a Model for HIV: An Overview. In Vivo Models of HIV Disease and Control, Springer. Infectious Diseases and Pathogenesis.","DOI":"10.1007\/b135975"},{"key":"ref_23","first-page":"219","article-title":"Acquired Immune Dysfunction in Cats with Experimentally Induced Feline Immunodeficiency Virus Infection: Comparison of Short-Term and Long-Term Infections","volume":"4","author":"Barlough","year":"1991","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Miller, C., Abdo, Z., Ericsson, A., Elder, J., and VandeWoude, S. (2018). Applications of the FIV Model to Study HIV Pathogenesis. Viruses, 10.","DOI":"10.20944\/preprints201804.0009.v1"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2460\/javma.245.8.916","article-title":"Association between Oral Health Status and Retrovirus Test Results in Cats","volume":"245","author":"Kornya","year":"2014","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Laitinen, T., Meili, T., Koyioni, M., Koutentis, P.A., Poso, A., Hofmann-Lehmann, R., and Asquith, C.R.M. (2022). Synthesis and evaluation of 1,2,3-dithiazole inhibitors of the nucleocapsid protein of feline immunodeficiency virus (FIV) as a model for HIV infection. Bioorg. Med. Chem., 68.","DOI":"10.1016\/j.bmc.2022.116834"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/v4050708","article-title":"Pharmacological Inhibition of Feline Immunodeficiency Virus (FIV)","volume":"4","author":"Mohammadi","year":"2012","journal-title":"Viruses"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Nastri, B.M., Pagliano, P., Zannella, C., Folliero, V., Masullo, A., Rinaldi, L., Galdiero, M., and Franci, G. (2023). HIV and Drug-Resistant Subtypes. Microorganisms, 11.","DOI":"10.3390\/microorganisms11010221"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1128\/AAC.33.6.915","article-title":"Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome","volume":"33","author":"North","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1124\/mol.65.1.244","article-title":"Susceptibility of Feline Immunodeficiency Virus\/Human Immunodeficiency Virus Type 1 Reverse Transcriptase Chimeras to Non-Nucleoside RT Inhibitors","volume":"65","author":"Auwerx","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-2427(01)00426-3","article-title":"Is AZT\/3TC therapy effective against FIV infection or immunopathogenesis?","volume":"85","author":"Arai","year":"2002","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/brain\/awm148","article-title":"Didanosine causes sensory neuropathy in an HIV\/AIDS animal model: Impaired mitochondrial and neurotrophic factor gene expression","volume":"130","author":"Zhu","year":"2007","journal-title":"Brain"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2460\/ajvr.75.3.273","article-title":"Antiviral efficacy of nine nucleoside reverse transcriptase inhibitors against feline immunodeficiency virus in feline peripheral blood mononuclear cells","volume":"75","author":"Schwartz","year":"2014","journal-title":"Am. J. Vet. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-3542(01)00190-5","article-title":"Combined effect of zidovudine (ZDV), lamivudine (3TC) and abacavir (ABC) antiretroviral therapy in suppressing in vitro FIV replication","volume":"53","author":"Bisset","year":"2002","journal-title":"Antivir. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1090-0233(98)80008-7","article-title":"Feline immunodeficiency virus infection: An overview","volume":"155","author":"Hartmann","year":"1998","journal-title":"Vet. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1128\/jvi.69.10.6149-6157.1995","article-title":"Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage","volume":"69","author":"Diehl","year":"1995","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kim, J., Behzadi, E.S., Nehring, M., Carver, S., Cowan, S.R., Conry, M.K., Rawlinson, J.E., VandeWoude, S., and Miller, C.A. (2023). Combination Antiretroviral Therapy and Immunophenotype of Feline Immunodeficiency Virus. Viruses, 15.","DOI":"10.3390\/v15040822"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Miller, C., Powers, J., Musselman, E., Mackie, R., Elder, J., and VandeWoude, S. (2019). Immunopathologic Effects of Prednisolone and Cyclosporine A on Feline Immunodeficiency Virus Replication and Persistence. Viruses, 11.","DOI":"10.3390\/v11090805"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"109413","DOI":"10.1016\/j.vetpar.2021.109413","article-title":"A probe-based droplet digital polymerase chain reaction assay for early detection of feline acute cytauxzoonosis","volume":"292","author":"Kao","year":"2021","journal-title":"Vet. Parasitol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Braun, K.M., Moreno, G.K., Halfmann, P.J., Hodcroft, E.B., Baker, D.A., Boehm, E.C., Weiler, A.M., Haj, A.K., Hatta, M., and Chiba, S. (2021). Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009373"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/s41379-020-0603-3","article-title":"A systematic review of pathological findings in COVID-19: A pathophysiological timeline and possible mechanisms of disease progression","volume":"33","author":"Polak","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41379-020-0536-x","article-title":"Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies","volume":"33","author":"Tian","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e13259","DOI":"10.1111\/eci.13259","article-title":"Histopathology and genetic susceptibility in COVID-19 pneumonia","volume":"50","year":"2020","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Tamil Selvan, M., Gunasekara, S., Xiao, P., Griffin, K., Cowan, S.R., Narayanan, S., Ramachandran, A., Hagen, D.E., Ritchey, J.W., and Rudd, J.M. (2022). SARS CoV-2 (Delta Variant) Infection Kinetics and Immunopathogenesis in Domestic Cats. Viruses, 14.","DOI":"10.3390\/v14061207"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Miller, C., Boegler, K., Carver, S., MacMillan, M., Bielefeldt-Ohmann, H., and VandeWoude, S. (2017). Pathogenesis of oral FIV infection. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0185138"},{"key":"ref_48","unstructured":"(2024, April 01). Artic Network. Available online: https:\/\/artic.network\/ncov-2019\/ncov2019-bioinformatics-sop.html."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nbt.3820","article-title":"Nextflow enables reproducible computational workflows","volume":"35","author":"Chatzou","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1093\/bioinformatics\/btv449","article-title":"SNPGenie: Estimating evolutionary parameters to detect natural selection using pooled next-generation sequencing data","volume":"31","author":"Nelson","year":"2015","journal-title":"Bioinformatics"},{"key":"ref_51","unstructured":"R Core Team, R. (2021). R Core Team R: A Language and Environment for Statistical Computing, R Core Team."},{"key":"ref_52","first-page":"13","article-title":"Epidemiological Aspects and Clinicopathological Findings in Cats Naturally Infected with Feline Leukemia Virus (FeLV) and\/or Feline Immunodeficiency Virus (FIV)","volume":"2012","author":"Collado","year":"2012","journal-title":"Sci. Res. Publ."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-4690-9-12","article-title":"FIV establishes a latent infection in feline peripheral blood CD4+ T lymphocytes in vivo during the asymptomatic phase of infection","volume":"9","author":"Murphy","year":"2012","journal-title":"Retrovirology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1292\/jvms.60.315","article-title":"Eight-year observation and comparative study of specific pathogen-free cats experimentally infected with feline immunodeficiency virus (FIV) subtypes A and B: Terminal acquired immunodeficiency syndrome in a cat infected with FIV petaluma strain","volume":"60","author":"Kohmoto","year":"1998","journal-title":"J. Vet. Med. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1016\/S2352-3018(21)00239-3","article-title":"Associations between HIV infection and clinical spectrum of COVID-19: A population level analysis based on US National COVID Cohort Collaborative (N3C) data","volume":"8","author":"Yang","year":"2021","journal-title":"Lancet HIV"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/jmv.26556","article-title":"COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2","volume":"93","author":"Mondi","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e701","DOI":"10.1016\/S2352-3018(21)00240-X","article-title":"Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: A retrospective cohort study","volume":"8","author":"Nomah","year":"2021","journal-title":"Lancet HIV"},{"key":"ref_58","unstructured":"Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases, South Africa (2021). Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa. Clin. Infect. Dis., 73, e2005\u2013e2015."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/jmv.26006","article-title":"Recovery from the coronavirus disease-2019 (COVID-19) in two patients with coexisted (HIV) infection","volume":"92","author":"Wu","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s15010-020-01438-z","article-title":"COVID-19 in people living with human immunodeficiency virus: A case series of 33 patients","volume":"48","author":"Spinner","year":"2020","journal-title":"Infection"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/cid\/ciaa635","article-title":"Clinical Characteristics and Outcomes in People Living with Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019","volume":"71","author":"Shalev","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10461-020-02983-2","article-title":"COVID-19 Among People Living with HIV: A Systematic Review","volume":"25","author":"Mirzaei","year":"2021","journal-title":"AIDS Behav."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.cmi.2021.06.023","article-title":"Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort","volume":"27","author":"Berenguer","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1177\/1098612X15610676","article-title":"Efficacy of antiviral chemotherapy for retrovirus-infected cats: What does the current literature tell us?","volume":"17","author":"Hartmann","year":"2015","journal-title":"J. Feline Med. Surg."},{"key":"ref_65","unstructured":"Ferreira, I., Datir, R., Papa, G., Kemp, S., Meng, B., Rakshit, P., Singh, S., Pandey, R., Ponnusamy, K., and Radhakrishnan, V.S. (2021). SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodies. BioRxiv."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Winger, A., and Caspari, T. (2021). The Spike of Concern\u2014The Novel Variants of SARS-CoV-2. Viruses, 13.","DOI":"10.3390\/v13061002"},{"key":"ref_67","first-page":"1","article-title":"SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/cid\/ciab411","article-title":"Neutralization of Variant under Investigation B.1.617.1 with Sera of BBV152 Vaccinees","volume":"74","author":"Yadav","year":"2022","journal-title":"Clin. Infect. Dis."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/7\/1289\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:03:57Z","timestamp":1760108637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/7\/1289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":68,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["microorganisms12071289"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms12071289","relation":{},"ISSN":["2076-2607"],"issn-type":[{"type":"electronic","value":"2076-2607"}],"subject":[],"published":{"date-parts":[[2024,6,25]]}}}